26 August 2016

Marland group moves into broker

Robert Tyerman

Former Tory treasurer Lord Marland, Carphone Warehouse co-founder David Ross and others plan to put £5 million into diversified stockbroker WH Ireland.

The powerful consortium, whose other members include investment banker Rupert Lowe, a former chairman of Southampton Leisure and director of the London International Financial Futures Exchange, has already paid £1.7 million at 100p a share for 9.9 per cent of Manchester-based WH Ireland. This move, which could have significant implications for the future of the company, is the first step in a process that the consortium hopes will bring it 26 per cent of an enlarged WH Ireland.

It follows one full takeover offer and another partial bid, both of which the company rejected. Under the purchase agreement, Lowe is to become non-executive chairman of the company, replacing former Conservative minister Sir David Trippier, and the entrepreneurial Marland, a financier and previously a leading light at Lloyd’s insurance broker Jardine Lloyd Thompson, joins the board as a non-executive director.

WH Ireland’s two largest shareholders, chief executive Laurie Beevers and managing director David Youngman, are selling parts of their holdings for £877,341 and £438,670 respectively. Subject to regulatory approval by the end of June, the consortium will buy another £1 million worth of shares, including £372,872 from Beevers, Youngman and associates, and then buy five million new shares at 100p each, taking its stake to 26 per cent.

The declared strategy is to expand WH Ireland, which made a flat £3.8 million last year on turnover up 41 per cent to £42.7 million through diversification, with possible acquisitions, following a recent £300,000 wealth management takeover, and partnerships. Beevers, who helped steer the company into corporate finance for junior resource companies from Australia and elsewhere, hopes the deal will help erase the company's 'provincial image' and enthuses that Marland and Lowe ‘are committed to supporting and developing the diversified strategy we have successfully pursued since our AIM admission in 2000’.

The shares, up 3.5p this morning to 111p and valuing WH Ireland at £18.9 million, are, in fact, 4p below the original AIM admission price, having fallen from 194p last October. Investors will hope the new backing and board members will speed recovery.

Growth Company Investor is the UK’s leading authority on small-cap and AIM companies. You can gain immediate access to all the recent share recommendations with no obligation, with a free 30-day trial. Click here to join today.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Retailers getting One View of their customers

One View listed on AIM via a reverse takeover back in March. It has developed software that provides retailers with a combined view of their customers history in both online and in-store shopping channels. This sort of digital engagement is a big opportunity for retailers to boost their sales.

Angle moves into the clinical trial stage

Angle is making good progress with its ‘Parsortix’ system which uses a precision-etched cassette to ‘sieve’ patient blood samples and capture cancerous tumour cells. The first major trial is now underway in ovarian cancer, led by the University of Vienna.

StatPro benefiting from a Revolution

StatPro shares have done well over the last month with the stock market giving the company credit for the growth in its new ‘Revolution’ product.

Tracsis signs key US deal

Transportation software specialist Tracsis has won a significant contract in the US. This looks like it could be a breakthrough which opens up the vast North American railroad market to this Leeds based company.

MedaPhor expands in ultrasound

MedaPhor came to the market two years ago and the £14 million market cap’s shares have done little since. However a couple of recent developments suggest they are worth keeping an eye on.

ScS sees no slowdown in sofas

ScS Group confirms it hasn't seen a slowdown in demand post-Brexit. Momentum has continued since the update in early June, with like-for-like sales order intake of 14.8 per cent for the first financial year ending in July.

More News